Climb Bio's total assets for Q1 2025 were $200.74M, a decrease of -7.57% from the previous quarter. CLYM total liabilities were $7.36M for the fiscal quarter, a 38.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.